Obalon Therapeutics, Inc.

Medtronic Vascular, Inc.

Dexcom, Inc.

Reshape Lifesciences Inc.

Other

Endologix, Inc.

Kaushik Aroonkumar Patel

Antonio C Llevares

Mark C Brister

Dubravka Markovic

Neil R Drake

Andrew P Rasdal

Nelson Quintana

Amy D L VandenBerg

Peter C Simpson

Jack Pryor

Robert James Boock

Paul V Neale

Matthew D Wightlin

Jeff Jackson

Jason Mitchell

Sebastian Bohm

Kishore Udipi

Peiwen Cheng

Susheel Deshmukh

Sebastian Böhm

Eugene Tedeschi

Rangarajan Sundar

Ronan Rogers

Randy Louis Werneth

David Hugo Deaton

Patrice Tremble

Carlos Ortega

Eric Noda

Swanand Sardesai

Amy Dl VandenBerg

Girma Kebede

Dianne Judd

Analyte sensors and methods of manufacturing same are provided, including analyte sensors comprising multi-axis flexibility. For example, a multi-electrode sensor systemcomprising two working electrodes and at least one reference/counter electrode is provided. The sensor systemcomprises first and second elongated bodies E, E, each formed of a conductive core or of a core with a conductive layer deposited thereon, insulating layerthat separates the conductive layerfrom the elongated body, a membrane layer deposited on top of the elongated bodies E, E, and working electrodes″ formed by removing portions of the conductive layerand the insulating layer, thereby exposing electroactive surface of the elongated bodies E, E

Analyte sensors and methods of manufacturing same

Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.

Intragastric volume-occupying device and method for fabricating same

An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.

Intragastric device

A system includes an inner filling structure around a stent-structure and an outer filling structure around the inner filling structure. The inner filling structure can be configured to produce a proximal seal with a first portion of an artery at a proximal end and a distal seal with a second portion of an artery at a distal end when the inner filling structure is in an inflacted state. The outer filling structure can have an inner surface surrounding at least a portion of the inner filling structure. The outer filling structure can be configured to be inflatable to occupy a space within an aneurysm at a lower pressure than a pressure in the inner filling structure.

Dual inflatable arterial prosthesis

A gastric device for a stomach having a pyloric valve comprising a first volume filling agent disposable within the stomach and transitionable from a first displacement to a second displacement larger than the first displacement, and wherein the first volume filling agent does not pass through the pyloric valve in the normal digestive process.

Temporary gastric device (TGD) and method of use

A gastric device for a stomach having a pyloric valve comprising a biodegradable delivery structure disposable within the stomach configured to erode upon exposure to gastric fluid. A first volume filling agent retained by the biodegradable delivery structure and is permeable to water and/or gastric fluids. A second volume filling agent retained by the first volume filling agent, wherein the second volume filling agent is a hydrogel that expands in contact with the water and/or gastric fluids thereby expanding the first volume filling agent from a first displacement to a second displacement larger than the first displacement, and wherein the first volume filling agent does not pass through the pyloric valve in the normal digestive process.

Analyte sensors and methods of manufacturing same are provided, including analyte sensors comprising multi-axis flexibility. For example, a multi-electrode sensor systemcomprising two working electrodes and at least one reference/counter electrode is provided. The sensor systemcomprises first and second elongated bodies E, E, each formed of a conductive core or of a core with a conductive layer deposited thereon, insulating layerthat separates the conductive layerfrom the elongated body, a membrane layer deposited on top of the elongated bodies E, E, and working electrodes&#x2033; formed by removing portions of the conductive layerand the insulating layer, thereby exposing electroactive surface of the elongated bodies E, E

Growing community of inventors

Poway, CA, United States of America

Kaushik Aroonkumar Patel